"Super-Flea" 2026: Why Frontline & Advantage Are Failing Your Pet — The Resistance Crisis Explained
Fipronil (Frontline) and imidacloprid (Advantage) resistance in Ctenocephalides felis has been confirmed in peer-reviewed 2024-2026 studies: ~37% of US flea populations from treated households show fipronil resistance; over 50% of UK populations in South-East England and East Midlands show imidacloprid resistance. Two mechanisms: metabolic resistance (elevated CYP450 enzymes detoxifying insecticide) and target-site kdr-type mutations. Zero resistance documented in isoxazolines (Bravecto, NexGard, Simparica, Credelio). This guide covers the science, US/UK resistance geography, differential diagnosis, resistance-proof alternatives product comparison, full 5-step environmental protocol, UK POM-V reclassification 2024, and manufacturer position statements.